
11 - 50 employees
Founded 2008
🏥 Healthcare
đź’Ľ Consulting
🎖️ Defense
🔥 Funding within the last year
đź’° $200M Post-IPO Equity - Immuneering on 2025-09
Healthcare • Consulting • Defense
Immuneering Corporation is a clinical-stage biotechnology company developing a novel class of oncology therapies called Deep Cyclic Inhibitors, which use rhythmic dosing to outpace cancer adaptation, improve tolerability, and extend patient survival and quality of life. The company advances a pipeline through clinical trials, collaborates with partners, and emphasizes scientific research and publications to transform cancer treatment while reducing side effects of traditional continuous-inhibition therapies.
🔥 2 minutes ago
🏄 California, New York, +1 more states – Remote
đź’µ $170k - $210k / year
⏰ Full Time
đźź Senior
đź‘” Director
đź‘» Ghost score 0%
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
Founded 2008
🏥 Healthcare
đź’Ľ Consulting
🎖️ Defense
🔥 Funding within the last year
đź’° $200M Post-IPO Equity - Immuneering on 2025-09
Healthcare • Consulting • Defense
Immuneering Corporation is a clinical-stage biotechnology company developing a novel class of oncology therapies called Deep Cyclic Inhibitors, which use rhythmic dosing to outpace cancer adaptation, improve tolerability, and extend patient survival and quality of life. The company advances a pipeline through clinical trials, collaborates with partners, and emphasizes scientific research and publications to transform cancer treatment while reducing side effects of traditional continuous-inhibition therapies.
• Oversee all aspects of the drug product development program from candidate nomination through clinical development • Conduct pre-formulation studies, including API form characterization and selection, with Process Chemistry • Design, execute and interpret formulation screening and excipient selection studies • Define phase-appropriate formulation approaches balancing clinical needs, manufacturability, regulatory expectations and commercial considerations • Develop robust, scalable and cost-effective drug product manufacturing processes • Direct drug product process development, technology transfer and manufacturing campaigns at external CDMOs • Review and approve process development protocols, master batch records, manufacturing campaign reports, executed batch records, quality investigations and batch disposition records • Provide person-in-plant support for manufacturing campaigns as required • Assist in establishing critical quality attributes and critical process parameters • Author or review development reports and risk assessments • Author assigned CMC sections for IND, IMPD, NDA and MAA filings and respond to regulatory agencies • Serve as drug product subject matter expert for cross-functional teams • Collaborate across CMC and the wider development team to deliver quality drug product for clinical trials • Maintain technical expertise in formulation and process development • Work in compliance with cGMP, safety and regulatory requirements • Report to the Head of CMC
• PhD in pharmaceutics, pharmaceutical sciences, chemical engineering, chemistry or related discipline with 8+ years of industry experience; or MS or BS degree in a related discipline with 12+ years of industry experience • Foundational understanding of pre-formulation studies, formulation design and development, and drug product manufacturing process development • Experience developing formulations for poorly soluble BCS Class II/IV compounds • Experience in drug product technology transfer and manufacture • Experience managing CDMOs for research, development and manufacturing campaigns • Solid understanding of FDA, EMA, and ICH regulatory guidelines • Ability to apply regulatory guidance to practical solutions and development strategies • Exceptional decision-making skills and ability to work independently in a fast-paced, high-pressure setting • Excellent technical writing skills, including regulatory submissions and responses to regulatory questions • Values-based leadership and commitment to integrity and ethics in pharmaceutical product development and manufacture • Preferred: background in dry/wet granulation, extrusion, spray drying, tableting and coating • Preferred: understanding of physicochemical and biopharmaceutical properties related to formulation design • Preferred: QbD, QTPP, CQA, CMA, CPP, FMEA and risk assessment experience • Preferred: pediatric formulation development • Preferred: HPLC, LC-MS, XRPD, DSC, dissolution and KF • Preferred: IND/IMPD and NDA/MAA submissions • Preferred: managing quality investigations
• Remote work • Travel: 10 to 20% • Inclusive and collaborative, mission-driven culture • Equal opportunity employment
Apply Now🔥 9 hours ago
Sr. Director leading Chronosphere’s global pre-sales organization for cloud-native observability. Scaling sales engineering, guiding enterprise deal strategy, and aligning technical execution with Palo Alto Networks’ cybersecurity mission.
🇺🇸 United States – Remote
đź’µ $389.7k - $454.6k / year
đź’° $1M Seed Round - Morta Security on 2013-02
⏰ Full Time
đźź Senior
đź‘” Director
🦅 H1B Visa Sponsor
🔥 13 hours ago
Senior Director leading GCP compliance and inspection readiness for Absci, a generative-AI biotechnology company. Driving clinical-trial oversight, remediation, audits, and regulatory preparedness.
🔥 13 hours ago
Novartis oncology account leader driving product adoption across priority healthcare accounts in Utah and Nevada. Developing strategic plans, executive relationships, and cross-functional launch initiatives.
🇺🇸 United States – Remote
đź’µ $168k - $312k / year
⏰ Full Time
đźź Senior
đź‘” Director
🦅 H1B Visa Sponsor
🔥 15 hours ago
Head of Integrations leading partner product strategy for G-P’s global employment SaaS platform. Driving enterprise integrations, adoption, revenue, and AI-enabled partner solutions.
🔥 15 hours ago
Associate Director optimizing field analytics, targeting, territories, and sales-force effectiveness for BeOne Medicines’ oncology products. Translating commercial data into actionable pharmaceutical growth strategies.